The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Agendia; Amgen; Aristo; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene/Jazz; ClinSol; Daiichi Sankyo; Eisai; Exact Sciences; Genomic Health; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; Medstrom Medical; MSD; Mundipharma; Mylan; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seagen; Tesaro; Teva; Veracyte; Viatris
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Genomic Health; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seagen; Tesaro; Teva
Speakers' Bureau - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Genomic Health; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seattle Genetics/Astellas; Tesaro; Teva
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Genomic Health; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seagen; Tesaro; Teva
 
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; ClearCut Medical; Clovis Oncology; Daiichi Sankyo Europe GmbH; Eisai Germany; Exact Sciences; Gilead Sciences; Lilly; Merck; MSD Oncology; Novartis; Pfizer; pfm medical; Roche; Seagen; Seagen; Servier/Pfizer; Servier/Pfizer; Sysmex; Vifor Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Becton Dickinson; Biom‘Up; ClearCut Medical; Clovis Oncology; Daiichi Sankyo/Astra Zeneca; Exact Sciences; Gilead Sciences; Lilly; Merck; MSD Oncology; Neodynamics; Novartis; Pfizer; pfm medical; Pierre Fabre; Roche; Seagen; Sysmex; Viatris
Research Funding - Endomag (Inst); Exact Sciences (Inst)
Expert Testimony - pfm medical
Travel, Accommodations, Expenses - ClearCut Medical; Lilly; Pfizer; pfm medical; Roche
Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2- early breast cancer (EBC): Results from the ADAPT trial.
 
Oleg Gluz
Honoraria - AstraZeneca; Celgene; Genomic Health; NanoString Technologies; Novartis; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Amgen; Daiichi Sankyo; Genomic Health; Gilead Sciences; Lilly; Merck Sharp & Dohme; MolecularHealth; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
 
Matthias Christgen
No Relationships to Disclose
 
Sherko Kuemmel
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Genomic Health; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Roche/Genentech; Seagen; SOMATEX; Sonoscape
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche; Sonoscape
(OPTIONAL) Uncompensated Relationships - West German Study Group
 
Christine zu Eulenburg
No Relationships to Disclose
 
Michael Braun
Consulting or Advisory Role - Exact Sciences; Novartis
Speakers' Bureau - Novartis
 
Bahriye Aktas
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Celgene; Daiichi Sankyo; Novartis; Pfizer; Roche
 
Kerstin Luedtke-Heckenkamp
Honoraria - AstraZeneca; AstraZeneca/Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - Merck Serono; Novartis; Roche; Seagen
Research Funding - Eisai (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Roche
 
Helmut Forstbauer
Honoraria - Roche; Roche
 
Eva-Maria Grischke
No Relationships to Disclose
 
Claudia Schumacher
No Relationships to Disclose
 
Katja Krauss
Stock and Other Ownership Interests - Sanofi
Honoraria - Roche Pharma AG
 
Marc Thill
No Relationships to Disclose
 
Mathias Warm
No Relationships to Disclose
 
Monika Karla Graeser
No Relationships to Disclose
 
Rachel Wuerstlein
No Relationships to Disclose
 
Ronald E. Kates
Honoraria - Amgen (I); Celgene (I); Genomic Health (I); NanoString Technologies (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Agendia (I); AstraZeneca (I); Celgene (I); Daiichi Sankyo (I); Lilly (I); Merck Sharp & Dohme (I); Novartis (I); Odonate Therapeutics (I); Pfizer (I); Roche/Genentech (I); Sandoz (I); Seagen (I)
 
Frederick L. Baehner
Employment - Exact Sciences
Leadership - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
 
Ulrike Nitz
Honoraria - Agendia; Amgen; AstraZeneca; Celgene; Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche/Genentech; Seagen
Consulting or Advisory Role - Genomic health; Roche
Research Funding - Amgen (Inst); Celgene (Inst); Exact Sciences (Inst); NanoString Technologies (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Exact Sciences
Travel, Accommodations, Expenses - Exact Sciences; Pfizer; Roche
 
Hans Heinrich Kreipe
Honoraria - Amgen; AstraZeneca; Genomic Health; Novartis; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Roche Pharma AG
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - Amgen; AstraZeneca; Daiichi-Sankyo; Exact Sciences; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sandoz; Seagen; West German Study Group (I)
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Roche/Genentech (Inst)